Notably, the oncogenic role of BCL2 is well-established in follicular lymphomas, where the juxtaposition of IgH-BCL2 is implicated in lymphomagenesis, perturbing normal B lymphocyte apoptosis (10). This evidence concerns the gene BCL2 and follicular lymphoma.